Saturday, June 27, 2009

CART (Cocaine- and Amphetamine-Regulated Transcript) Peptides

Definition

Cocaine- and amphetamine- regulated transcript (CART) peptides, derived from proCART polypeptide in humans are neuropeptides expressed in the brain1. They mainly serve as inhibitors of food intake1.

Discovery

CART was first purified by gel filtration and sequenced in 1980 from rat hypothalamus2.

Classification

CART is a neuropeptide family member2.

Structural Characteristics

CART gene encodes a peptide of either 129 or 116 amino acid residues in rat whereas only the short form exists in humans. The predicted signal sequence is 27 amino acid residues resulting in a precursor of 102 or 89 residues3. The C-terminal end of CART, consisting of 48 amino acid residues and 3 disulphide bonds, is thought to constitute a biologically active part of the molecule. Various CART peptides can be generated from the precursor: CARTs (55-102), (85-102), (55-76) and (62-76)3. CART (55-102) contains three disulphide bridges that are required for its function4.



Mode of action

The mode of action of CART peptides has not been fully established. Several studies have observed that they may function through CART receptors in turn activating down stream signaling pathways5.



Functions

CART is distributed in the central nervous system and periphery and has many physiological roles. It elicits similar behavior as cocaine. CART has been shown to have variety of effects on dopamine6. It increases blood pressure, has variety of behavioral effects and influences nociception6. In the hypothalamus CART mainly regulates energy homeostasis6. CART is also an endogenous inhibitor of food intake6. CART peptides are also important in anxiety, pain, arousal, startle response, regulation of calcium channels, and neuroendocrine hormone secretion5.





References



1. Thim L, Kristensen P, Larsen PJ, Wulff BS (1998). CART, a new anorectic peptide. Int J Biochem Cell Biol, 30(12), 1281-4.

2. Spiess J and Vale W (1980). Multiple forms of somatostatin-like activity in rat hypothalamus. Biochemistry 19, 2861–66.

3. Dylag T, Kotlinska J, Rafalski P, Pachuta A, Silberring J (2006). The activity of CART peptide fragments. Peptides, 27(8), 1926-33.

4. Murphy KG (2005). Dissecting the role of cocaine and amphetamine-regulated transcript (CART) in the control of appetite. Briefing in Functional Genomics and proteomic, 4 (2), 95–111.

5. Rogge G, Jones D, Hubert GW, Lin Y & Kuhar MJ (2008). CART peptides: regulators of body weight, reward and other functions. Nature Reviews Neuroscience, 9, 747-758.

6. Vicentic A, Jones DC (2007). The CART (cocaine- and amphetamine-regulated transcript) system in appetite and drug addiction. J Pharmacol Exp Ther., 320(2), 499-506.

CaMK II (Ca2+/calmodulin-dependent protein kinase II)

Definition

Ca2+/calmodulin-dependent protein kinase II (CaMKII) is a Ser/Thr protein kinase whose activity is regulated by Ca2+/calmodulin (CaM) complex1. It is predominant in the heart and plays an important role during excitation contraction coupling2.

Discovery

CaMKII was first purified from rat brain by gel filtration techniques while monitoring the activation of tryptophan hydrolase and phosphorylation of endogenous proteins3.

Classification

CaMK proteins belong to the kinase family4. CaMKII belongs to the CaMK subfamily of proteins which include the following members: CaMKI, CaMKII-alpha subunit, CaMKII-beta subunit, CaMKII-gamma subunit, CaMKII-delta subunit, CaMKIII and CaMKIV4.

Structural Characteristics

The four isoforms of CaMKII (a,b,g,d) are all encoded by different genes. a and b are predominant neural isoforms while g and d isoforms are expressed in many tissues including the heart. The CaMKII consists of an N-terminal catalytic domain followed by autoinhibitory, Ca2+/CaM binding and association domains5. Predicted CaMKII phosphorylation consensus motifs generally follow the form R-X-X-S/T. The autoinhibitory domain consists of a pseudosubstrate sequence that, under basal conditions, binds and constrains the catalytic domain5. The pseudosubstrate sequence is built around an activating "autophosphorylation" site at Thr286/287 (the precise numbering is isoform dependent). The enzyme assembles into dodecameric or tetradecomeric structures, with the catalytic domains sticking out, such that these may phosphorylate residues in an intersubunit fashion that increases their affinity to CaM complex5. In the absence of Ca2+/calmodulin, the autoinhibitory domain inhibits the catalytic domain6.

Mode of action

When intracellular Ca2+ increases, CaM binds up to four Ca2+ ions to form the Ca2+/CaM complex that binds to the regulatory domain of CaMKII thereby activating the enzyme with half maximal activation at Ca2+. After this Ca2+/CaM-dependent activation, CaMKII autophosphorylates Thr286/287 on the autoinhibitory segment resulting in a completely active enzyme that can maintain CaMK active even after Ca2+ has declined5. Activated CaMKII can phosphorylate various substrates5.

Functions

CaMKII modulates excitation-contraction coupling in the heart by regulating several Ca2+ handling proteins5. CaMKII has also been implicated in Ca2+ dependent axonal growth cone attraction, synaptic plasticity, learning and memory7. Excess CaMKII is associated with heart failure. Hence CaMK inhibitors are being designed in order to study their effect on reducing heart failure5.

References

1. Maier LS (2009). Role of CaMKII for signaling and regulation in the heart. Front Biosci., 14:486-96.

2. Wayman GA, Lee YS, Tokumitsu H, Silva A, Soderling TR (2008). Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron, 59(6), 914-31.

3. Yamauchi, T. and Fujisawa, H. (1980). Evidence for three distinct forms of calmodulin-dependent protein kinases from rat brain. FEBS Lett. 116, 141-144.

4. Steven KH and Tony H (1995). The eukaryotic protein kinase superfamily: kinase (catalytic) domam structure and classification. The Faseb Journal, 29, 576-96.

5. Couchonnal LF, Anderson ME (2008). The role of calmodulin kinase II in myocardial physiology and disease. Physiology (Bethesda).23:151-9.

6. Rosenberg OS, Deindl S, Sung RJ, Nairn AC, Kuriyan J (2005). Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme. Cell, 123, 849–860.

7. Lars SM and Donald MB (2007). Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation–contraction coupling in the heart. Cardiovascular Research, 73(4), 631-640.

CaMK (Ca2+/calmodulin-dependent protein kinase)

Definition

Ca2+/calmodulin-dependent protein kinase (CaMK) are a family of Ser/Thr protein kinases whose activity is regulated by Ca2+/calmodulin (CaM) complex and on activation, phosphorylate their protein substrates to alter their functionality1. They are primarily located in the brain and play a critical role in neuronal development, plasticity and behavior1.

Discovery

In 1979, the idea that CaMK exists arose from the observation that most of the Ca2+-dependent endogenous phosphorylation of rat brain cytosol proteins require calmodulin2. Later, in 1980, CaMKII was purified from rat brain by gel filtration techniques while monitoring the activation of tryptophan hydrolase and phosphorylation of endogenous proteins3.

Classification

CaMK proteins belong to the kinase family4. CaMK subfamily of proteins includes the following members: CaMKI, CaMKII-alpha subunit, CaMKII-beta subunit, CaMKII-gamma subunit, CaMKII-delta subunit, CaMKIII and CaMKIV4.

Structural Characteristics

The CaM kinases consist of an N-terminal catalytic domain followed by autoinhibitory and Ca2+/CaM binding domains. In addition CaMKII proteins have an association domain5. The enzymes assemble into dodecameric holoenzyme structures, with the catalytic domains sticking out, such that these may phosphorylate residues in an intersubunit fashion that increases their affinity to CaM complex6. In the absence of Ca2+/calmodulin, the autoinhibitory domain inhibits the catalytic domain6. Several CaM kinases aggregate into a homooligomer or heterooligomer. Phosphorylation at residues 286/305/306, which are all threonines, have a negative effect on binding of Ca2+/calmodulin complex to enzyme subunits, thus reducing function6.

Mode of action

When intracellular Ca2+ increases, CaM binds up to four Ca2+ ions to form the Ca2+/CaM complex that binds to the regulatory domain of CaMK thereby activating the enzyme with half maximal activation at Ca2+. After this Ca2+/CaM-dependent activation, CaMK autophosphorylates Thr287 on the autoinhibitory segment resulting in a completely active enzyme that can maintain CaMK active even after Ca2+ has declined7. Activated CaMKs can phosphorylate various substrates7.

Functions

CaMK proteins play an important role in the development of neurons8. CaMKK/CaMKI is involved in regulation of axonal growth cone morphology/motility and axonal outgrowth, dendritic arborization, and formation of dendritic spines8. CaMKII modulates excitation contraction coupling in the heart by regulating several Ca2+ handling proteins8. CaMKII has also been implicated in Ca2+ dependent axonal growth cone attraction, synaptic plasticity, learning and memory1. CaMKIV promotes dendritic growth by the activationof ErK1.

References


1. Wayman GA, Lee YS, Tokumitsu H, Silva A, Soderling TR (2008). Calmodulin-kinases: modulators of neuronal development and plasticity. Neuron, 59(6), 914-31.

2. Yamauchi T and Fujisawa H (1980). Evidence for three distinct forms of calmodulin-dependent protein kinases from rat brain. FEBS Lett., 116, 141-144.

3. Yamauchi T, Fujisawa H (1979). Most of the Ca2+-dependent endogenous phosphorylation of rat brain cytosol proteins requires Ca2+-dependent regulation protein. Biochem Biophys Res Commun., 90(4), 1172-8.

4. Steven KH and Tony H (1995). The eukaryotic protein kinase superfamily: kinase (catalytic) domam structure and classification. The Faseb Journal, 29, 576-96.

5. Thomas RS and James TS (2001). Structure and Regulation of Calcium/Calmodulin-Dependent Protein Kinase. Chem. Rev., 101 (8), 2341–52.

6. Rosenberg OS, Deindl S, Sung RJ, Nairn AC, Kuriyan J (2005). Structure of the autoinhibited kinase domain of CaMKII and SAXS analysis of the holoenzyme. Cell, 123, 849–860.

7. Lars SM and Donald MB (2007). Role of Ca2+/calmodulin-dependent protein kinase (CaMK) in excitation–contraction coupling in the heart. Cardiovascular Research, 73(4), 631-640.

8. Alicia M, Leticia V and Cecilia MW (2007). Ca2+/calmodulin-dependent protein kinase: A key component in the contractile recovery from acidosis. Cardiovascular Research, 73(4), 648-656.

DNA damage actually causes gray hair

While many people attribute gray hair to age, a new, Japanese study has revealed that it really is a sign of stress. A cellular stress. This study was published in the June 12, 2009 issue of Cell journal.

Stress which damages DNA is referred to as genotoxic stress. In this case, when specialized cells, called melanocyte stem cells, (MSCs) are damaged, it ultimately results in a malfunction of those cells which express hair color. Genotoxic stress can deplete the MSCs in hair follicles that make the pigment-producing melanocytes. However, when exposed to the stress, the MSCs actually differentiate into mature melanocytes, as opposed to dying off. This means that if the genotoxic stress can be limited, graying may actually be halted.

Virtually all cells are exposed to some form of genotoxic stress, every day. However, cells are built to handle the stress and repair damaged DNA, and even work to prevent the damage from being passed on to daughter cells. However, once stem cells are irreparably damaged, they must be eliminated so that the quality of the stem cells pools can be maintained. Stresses on stem cell pools and genome maintenance failures are also thought responsible for the decline of tissue renewal capacity and the accelerated appearance of aging-related characteristics.

“We found that excessive genotoxic stress triggers differentiation of melanocyte stem cells,” said Emi Nishimura of Tokyo Medical and Dental University, who led the research team. Nishimura's team had previously traced graying hair to the gradual dying off of the stem cells that manufacture a continuous supply of new melanocytes, which are responsible for hair's youthful color. The study found that those specialized stem cells are not only lost, they also differentiate into fully committed pigment cells, and in the wrong place.

The study supports the idea that genome instability is a major factor in aging. It also supports the “stem cell aging hypothesis”, which states that DNA damage to stem cells can be attributed to many of the conditions that come with age.

“In this study, we discovered that hair graying, the most obvious aging phenotype, can be caused by the genomic damage response through stem cell differentiation, which suggests that physiological hair graying can be triggered by the accumulation of unavoidable DNA damage and DNA-damage response associated with aging through MSC differentiation,” the researchers wrote.

Cell Penetrating or “Trojan” Peptides - CPP

Cell Penetrating or “Trojan” Peptides

During the last ten years it has been observed that a number of peptides and proteins are able to penetrate the cell membrane and enter the cell. Furthermore, it has been shown that even many cargo molecules that are covalently attached to these peptides will be translocated into the cell. Peptides that show the ability to translocate through the cell membrane are usually short peptides of less than 30 amino acids. Their only common feature appears to be that they are amphipathic and have a overall positive net charge. The exact mechanism of cell translocation is not known but appears to be receptor and energy independent, although in some cases their translocation can be partially mediated by endocytosis. The penetration into cells is usually rapid and of first-order, with half-times from 5 to 20 minutes [Zorko, M., and Langel, U., 2005].

The ability of a 60-amino acid polypeptide corresponding to the sequence of the Drosophila antennapedia gene homeobox to traverse across cell membranes of nerve cells and accumulate in the nuclei was first reported by Joiliot et al, in 1991. A shorter peptide coined penetratin is a 16 amino acids long peptide of cationic nature containing the sequence: RQIKIWFQNRRMKWKK. This sequence derives from helix 3 of the antennapedia complex [Thoren, P.E., et al., 2003; Fischer, P.M., et al., 2000] and is able to translocate through the plasma membrane to the cytosol and nucleus of living cells, both at 37 °C and 4 °C respectively.

Recently, methods have been developed for the delivery of exogenous proteins into living cells with the help of membrane-permeating carrier peptides derived from HIV-1 Tat (residues 48 to 60) and antennapedia (residues 43 to 58), penetratin [Derosssi, D., et al., 1998; Dunican D.J., et al., 2001]. The basic nature of these peptides and the locations of aromatic groups within their sequence allows these peptides to penetrate the cell membrane. Investigating a range of basic peptides, Futaki reported that a peptide containing eight arginine residues can efficiently translocate across the cell membrane [Futaki, S. 2002]. Recently, a chimeric peptide derived from galparan and transportan has been used as an effective peptide vector for biodelivery of BNA molecules [Pooga, Marcus., et.al., 1998]. Translocation of the penetratin peptide occurs even when it is coupled to hydrophilic molecules (e.g. phosphopeptides, oligonucleotides, peptidic nucleic acids, drugs, etc.) [Prochiantz, A., 1996]. Taking the “Illyad” a tale from the Greek mythologies as an example these cell-penetrating peptides (CPP) were also termed ‘Trojan’ peptides. Most of them are water-soluble peptides with a low lytic activity that can be used as vectors for cellular internalization of hydrophilic biomolecules and drugs [Lindgren, M., et al., 2000, Stephens, D.J., & Pepperkok, R. 2001]. Despite its broad application field, the internalization mechanism of the penetratin peptide has not been totally unraveled yet. It appears that a receptor or a transporter protein is not needed, as retro-enantio and retro-inverso analogs of penetratin are also internalized [Derossi, D., et al., 1996]. Presumably, cellular internalization of the penetratin peptide occurs via a direct interaction with the cell membrane [Prochiantz, A., 1996)].

Table 1 (below) contains a list of peptides that have been investigated for their ability to penetrate the cell. The potential to inhibit specific mRNA export pathways using cell-permeable peptides is shown in figure 1. Cell-penetrating peptide inhibitors are inhibiting their target proteins rapidly. In that sense they could be superior to other “functional knockout” approaches such as RNA interference (RNAi). RNAi prevents translation of a protein by destroying its mRNA; however, a long-lived protein will continue to be active long after its synthesis has stopped. The more rapidly a peptide affects RNA export, the more likely it is that the peptide directly (rather than indirectly) inhibits export of the target RNA. It is conceivable that designer inhibitory peptides based on the sequences of cell-penetrating peptides have the potential to allow for the generation of a mammalian cell tool kit that could parallel the temperature-sensitive mutant collection available to yeast geneticists [Moore and Rosbash, 2001].

Table 1: Peptides that translocate into the cell (Futaki, S. 2005)




Residues highlighted in dark bold blue indicate a positive charge where as the ones highlighted in bold red indicate negative charges.



Figure 1: The potential to inhibit specific mRNA export pathways with cell-permeable peptides. The major route of mRNA export from the nucleus may depend on interactions between the mRNA adaptor protein Aly/REF and the export receptor heterodimer TAP:p15, which in turn interacts with the nuclear pore complex. New inhibitors that couple cell-penetrating peptides with specific nuclear export signals reveal that some mRNAs use other adaptors and receptors. For example, there are two nuclear export pathways for c-fos mRNA. One pathway involves the adaptor protein HuR and the export receptor Trn2, whereas the other involves HuR, its two ligands (pp32 and APRIL) and the export receptor CRM1. [Melissa J. Moore and Michael Rosbash in SCIENCE VOL 294 p. 1841, 2001].

3D structures


Figure 2: Three-dimensional structure of the antennapedia homeodomain protein-DNA complex. (Protein Data Bank accession code 9ant). A: The protein is shown as the space-fill model whereas the DNA is displayed in ball-and-stick (one DNA strand) and stick mode (second DNA strand). B: Only the peptide corresponding to penetratin peptide is now displayed in the space-filling mode all other atoms are in the stick mode. It is apparent that the peptide is in close contact with the DNA molecule apparently binding to the major groove of the helix.



Figure 3: Three-dimensional solution structure of penetratin. (Protein Data Bank accession code 1kz0). Amino acid side chains of basic amino acid residues are highlighted in blue. The tryptophans are shown in purple. The primary structure of the peptides is also provided. All pictures were generated with the 3D mol viewer of Vector NT (version 6, Invitrogen, USA).

References

  1. Derossi, D., Calvet, S., Trembleau, A., Brunissen, A., Chassaing, G. & Prochiantz, A. (1996) Cell internalization of the third helix of the Antennapedia homeodomain is receptor-independent. J. Biol. Chem. 271, 18188–18193.
  2. Derossi, D., Chassaing, G. & Prochiantz, A. (1998) Trojan peptides: the penetratin system for intracellular delivery. Trends Cell Biol. 8, 84–87.
  3. Dunican, D.J. & Doherty, P. (2001) Designing cell-permeant phosphopeptides to modulate intracellular signaling pathways. Biopolymers 60, 45–60.
  4. Fischer, P.M., Zhelev, N.Z., Wang, S., Melville, J.E., Fahraeus, R. & Lane, D.P. (2000) Structure-activity relationship of truncated and substituted analogues of the intracellular delivery vector Penetratin. J. Pept. Res. 55, 163–172
  5. Futaki, S. (2002) Arginine-rich peptides: potential for intracellular delivery of macromolecules and the mystery of the translocation mechanisms. Int. J. Pharm. 245, 1–7.
  6. Futaki, S. (2002) Membane-permeable arginine-rich peptides and the translocation mechanisms. Adv. Drug Del. Reviews 57, 547-558.
  7. Joliot, A., Pernelle, C., Deagostini-Bazin, H. & Prochiantz, A. (1991) Antennapedia homeobox peptide regulates neural morphogenesis. Proc. Natl Acad. Sci. USA 88, 1864–1868
  8. Lindgren, M., Hallbrink, M., Prochiantz, A. & Langel, U. Cell-penetrating peptides. (2000) Trends Pharmacol. Sci. 21, 99–103.
  9. Moore, M.J., and Rosbash, M., (2001) Cell biology. TAPing into mRNA export. Science 294, 1841-2.
  10. Pooga,M., Halbrink, M, Zorko, M, Langel, U., (1998) Cell Penetration by Transportan. FASEB Journal,12;67-77.
  11. Pooga M, Land T, Bartfai T, Langel U. (2001) PNA oligomers as tools for specific modulation of gene expression. Biomol Eng. 2001 Jun;17(6):183-92.
  12. Prochiantz, A. (1996) Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr. Opin. Neurobiol. 6, 629–634.
  13. Prochiantz, A. (1996) Getting hydrophilic compounds into cells: lessons from homeopeptides. Curr. Opin. Neurobiol. 6, 629–634.
  14. Saalik P, Elmquist A, Hansen M, Padari K, Saar K, Viht K, Langel U, Pooga M. (2004) Protein cargo delivery properties of cell-penetrating peptides. A comparative study. Bioconjug Chem. Nov-Dec;15(6):1246-53.
  15. Stephens, D.J., & Pepperkok, R. The many ways to cross the plasma membrane. (2001) Proc. Natl Acad. Sci. USA 98, 4295–4298
  16. Thorén, P.E., Persson, D., Isakson, P., Goksör, M., Önfelt, A. & Nordén, B. (2003) Uptake of analogs of penetratin, Tat (48–60) and oligoarginine in live cells. Bioch. Biophys. Res. Comm. 307, 100–107.
  17. Zorko, M. and Langel, U., (2005) Cell-penetrating peptides: mechanism and kinetics of cargo delivery. Adv. Drug Del. Reviews 57, 529-545.

Thursday, June 25, 2009

Band 3 Protein Fragments

Definition
Band 3 protein fragments are phylogenetically preserved transport peptides located on the organelle membranes especially the erythrocyte membrane where they mediate anion exchange1.

Discovery
Band 3 peptides were originally identified following SDS-gel electrophoresis of erythrocyte cell membrane. The large third band on the gel turned out to be the peptide. Hence the name Band 31.

Classification
Band 3 proteins are members of anion-exchange (AE) family of proteins2. AE proteins are encoded by a multigene family that has atleast three genes, AE1, AE2, AE3 and several splicioforms2. They are all expressed by most cells, e.g., erythrocytes, cardiomyocytes.

Structural Characteristics
Band 3 fragments have two functional domains.The integral domain mediates a 1:1 exchange of inorganic anions across the membrane, whereas the cytoplasmic domain provides binding sites for cytoskeletal proteins, glycolytic enzymes, and hemoglobin3. Activation of Band 3 fragments occurs through tyrosine phosphorylation4.

Mode of action
Band 3 peptide is bound to the erythrocyte membrane5. Its N-terminal region protrudes from the main body towards the red cell cytoplasm allowing it to interact with various membrane bound and cytoplasmic red cell components such as glycolytic enzymes including aldolase, glyceraldehyde-3-phosphate dehydrogenase and phosphofructokinase as well as other membrane components such as ankyrin and protein 4.15,6. Recently it has been found that Band 3 also binds to Hemoglobin. Interaction of Band 3 with these proteins exerts several changes in the cells for example lowering oxygen affinity of Hemoglobin5.

Functions
Band 3 fragments are involved in the anion-exchange across the plasma membrane on a one-for-one basis. This is crucial for CO2 uptake by the red cell and conversion into a proton and a bicarbonate ion that is then extruded from the cell by the band 3 molecule2. Band 3 serves as a physical linkage between the plasma membrane and the underlying membrane skeleton via binding with ankyrin and protein 4.15. This appears to prevent membrane surface loss. A spliced variant of Band 3 nAE1 regulates pH in cardioventricular myocytes through anion-exchange2. Band 3 is also an allosteric regulator of Heamoglobin as it binds to Hb and decreases its affinity for oxygen5. Other functions of Band 3 fragments include maintenance of cell volume and osmotic homeostasis, red cell aging, IgG binding and cellular removal7. Band 3 alterations are implicated in neurological diseases such as familial paroxysmal dyskinesia, idiopathic generalized epilepsies, and neuro- or choreoacanthocytosis7.

References
1.Hunter M (1977). Human erythrocyte anion permeabilities measured under conditions of net charge transfer. J Physiol, 268 (1): 35–49.
2.Richards SM, Jaconi ME, Vassort G and Puceat M (1999). A spliced variant of AE1 gene encodes a truncated form of Band 3 in heart: the predominant anion exchanger in ventricular myocytes.
3.Jonathan DG, Lin W and Michael JAT (1998). Complementation studies with co-expressed fragments of human red cell band 3 (AE1): the assembly of the anion-transport domain in Xenopus oocytes and a cell-free translation system. Biochem. J., 332, 161-171.
4.Yannoukakos D, Vasseur C, Piau JP, Wajcman H, Bursaux E (1991). Phosphorylation sites in human erythrocyte band 3 protein. Biochim. Biophys. Acta, 1061, 253-266.
5.Yuxun Z, Lois RM, Jill F, Orah P and James MM (2003), Human Erythrocyte Membrane Band 3 Protein Influences Hemoglobin Cooperativity: Possible effect on oxygen transport. J. Biol. Chem., 278, 41, 39565-39571.
6.Chambers EJ, Askin D, Bloomberg GB, et al. (1998). Studies on the structure of a transmembrane region and a cytoplasmic loop of the human red cell anion exchanger (band 3, AE1), Biochem. Soc. Trans., 26 (3): 516–20.
7.Kay MM (2004). Band 3 and its alterations in health and disease. Cell Mol Bio, 52, 117-38.

BAM (Bovine Adrenal Medulla) Peptides

Definition
Bovine adrenal medulla (BAM) peptides are peptides secreted in the adrenal gland that exhibit potent opioid activity1.

Discovery
BAM peptides were first purified from bovine adrenal medulla and it was found that upon their trypsinization they can yield the other enkephalin peptide-Met Enkephalin2.

Classification
BAM peptides are cleavage products of the opioid peptide, pro-enkephalin. There are atleast three different BAM peptides that have been identified so far: BAM 12P, 20P and 22P3.

Structural Characteristics
BAM 22P is a docosa peptide that is a cleavage product of pro-enkephalin. BAM 20P and BAM 12P are C-terminal shortened versions of BAM 22P2.

Mode of action
BAM peptides normally bind to opioid receptors on neural cells and trigger a response. For instance, BAM22P binds to G-Protein coupled sensory neuro receptors and opioid receptors which when activated trigger a series of pain signals4.

Functions
BAM peptides mainly expressed in the central nervous system have potent opioid activity. BAM22P inhibits reflex bladder action, induces analgesic response in mice and also exerts a protective action during stress such as shock or injury4. The exact functions of other BAM peptides remain unclear.

References
1.Swain MG, MacArthur L, Vergalla J and Jones EA (1994). Adrenal secretion of BAM-22P, a potent opioid peptide, is enhanced in rats with acute cholestasis. Am J Physiol Gastrointest Liver Physiol , 266, G201-G205.
2.Mizuno K, Minamino N, Kangawa K and Matsuo H (1980). A new family of endogenous “big” met-enkephalins from bovine adrenal medulla: purification and structure of docosa- (BAM-22P) and eicosapeptide (BAM-20P) with very potent opiate activity. Biochem. and Biophy. Res. Comm., 47, 1283-90.
3.Book: Frank M and Klaus V, Molecular and Cellular Exercise Physiology.
4.Yanguo H, Peifang D, Jianping J and Xueai Z (2004). Dual effects of intrathecal BAM22 on nociceptive responses in acute and persistent pain–potential function of a novel receptor. Br J Pharmacol, 141(3): 423–430.

Brain Natriuretic Peptides (BNP)

Definition
Brain natriuretic peptide (BNP) is a 32 amino acid polypeptide that is secreted by the ventricles of the heart in response to stretching of heart muscles1.

Discovery
BNP was first discovered in porcine brain extracts based on its resemblance to atrial natriuretic peptide (a hormone secreted by mammalian atria) 1.

Classification
BNP belongs to the natriuretic family of peptides that contain three structurally related paracrine factors: Atrial, Brain and C-type natruirectic peptides2. Both atrial and brain natriuretic peptides are secreted in the atria and ventricles of the heart while C-type peptide is secreted in the bone2. BNP is co-secreted along with a 76 amino acid N-terminal fragment (NT-proBNP) which is biologically inactive3.

Structural Characteristics
BNP is a horseshoe-shaped 32 amino acid peptide that is held by a disulphide bridge formed between amino acids 10 and 264. It is produced by cleavage of large precursors- prepro and prohormones4.

Mode of action
BNP activates a transmembrane guanylyl cyclase, natriuretic peptide receptor-A (NPR-A). Activated NPR-A in turn produces the second messanger cGMP that triggers effectors that mediate its cardiac functions5,6.

Functions
BNP similar to ANP decreases systemic vascular resistance and central venous pressure resulting in a decrease in cardiac output and blood volume7. Both BNP and NT-proBNP levels in the blood are used for screening, diagnosis of acute congestive heart failure (CHF) and may be useful to establish prognosis in heart failure, as both markers are typically higher in patients with worse outcome8. The plasma concentrations of both BNP and NT-proBNP are also typically increased in patients with asymptomatic or symptomatic left ventricular dysfunction8.

BNP plays a very important role in prognostication of millions of diabetics9. It has an improtant role in prognostication of heart surgery patients10. It has been shown that combining BNP with other tools like ICG can improve early diagnosis of heart failure and advance prevention strategies11. BNP can be elevated in renal failure12. The BNP test is used as an aid in the diagnosis and assessment of severity of congestive heart failure (also referred to as heart failure)13.

References
1.Tetsuji S, Kenji K, Naoto M and Hisayuki M (1988), A new natriuretic peptide in porcine brain, Nature, 332, 78-81.
2.Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM (2009), Natruiretic peptides: their structures, receptors, physiologic functions and therapeutic applications, Handb Exp Pharmacol, 191, 341-66.
3.Bibbins-Domingo K, Gupta R, Na B, Wu AH, Schiller NB, Whooley MA (2007). "N-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patients with stable coronary heart disease". JAMA 297 (2): 169–76.
4.Brandt I, Lambeir AM, Ketelsleger JM, Vanderheyden M, Scharpé S and Meest ID, (2006), Dipeptidyl-peptidase IV converts intact B-type natriuretic peptide into its des-SerPro form. Clin. Chem, 52(1): 82-87.
5.David G. Lowe (1992), Human natriuretic peptide receptor-A guanylyl cyclase is self-associated prior to hormone binding, Biochemistry, 31 (43), pp 10421–10425.
6.Jun S, Peter M. S and Harvey R. W, (2005), Differential Effects of cGMP Produced by Soluble and Particulate Guanylyl Cyclase on Mouse Ventricular Myocytes, Experimental Biology and Medicine 230:242-250.
7.Bhalla V, Willis S, Maisel AS (2004). "B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure". Congest Heart Fail 10(1 Suppl 1): 3–27.
8.Atisha D, Bhalla MA, Morrison LK, Felicio L, Clopton P, Gardetto N, Kazanegra R, Chiu A, Maisel AS (2004). "A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction". Am. Heart J. 148 (3): 518–23.
9.Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman SV, Henry RR, Maisel AS (2004). "Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus". J. Am. Coll. Cardiol. 44 (5): 1047–52.
10.Lee CY, Burnett JC Jr. (2007), Natruiteric peptides and therapeutic applications, Heart Fail Rev, 12 (2), 131-42
11.Castellanos LR, Bhalla V, Isakson S, Daniels LB, Bhalla MA, Lin JP, Clopton P, Gardetto N, Hoshino M, Chiu A, Fitzgerald R, Maisel AS (2009). "B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events". J. Card. Fail. 15 (1): 41–7.
12.Bhalla V, Maisel AS (June 2004). "B-type natriuretic peptide. A biomarker for all the right reasons". Ital Heart J 5 (6): 417–20.
13.Fitzgerald RL, Cremo R, Gardetto N, Chiu A, Clopton P, Bhalla V, Maisel AS (2005). "Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure". Am. Heart J. 150 (3): 471–7.

Bag Cell Peptides

Definition
Bag cell peptides (BCPs) are a class of small neuropeptides secreted by the bag cell neurons in the marine mollusk Aplysia1. They trigger a series of reproductive behavior in this mollusk that finally culminates in egg-laying1.

Discovery
BCPs were originally identified in the bag cell extracts of abdominal ganglion of mature Aplysia that were obtained in Venice, CA2. They were isolated based on their ability to cause bag cell excitation2.

Classification
Bag cell specific gene that encodes for the precursor form of the egg laying hormone also contains sequences that encode several small BCPs: a-BCP, b-BCP, g-BCP2, d-BCP3,4 and e-BCP5.

Structural Characteristics
a-BCP is a 9 amino acid (Ala-Pro-Arg-Leu-Arg-Phe-Tyr-Ser-Leu) neuro tramsmittor whose Phe6-Tyr7 is necessary and sufficient for its function6. It does not undergo any NH2 or COOH modifications. b-BCP (Arg-Leu-Arg-Phe-His)7 and g-BCP are five amino acid peptides while d-BCP and e-BCP contain 39 and 19 amino acid residues respectively5.

Mode of action
Excitation of Bag Cell neurons triggers an afterdischarge response that results in the secretion of BCPs8. In addition, once the afterdischarge is underway, peptide release occurs in response to both calcium influx from the extracellular space and calcium release from intracellular stores8. Upon secretion the BCPs are packaged into discrete vescicles that are distributed throughout the central nervous system of Aplysia where they exert their functions4.

Functions
Release of egg-laying hormone and BCPs mediates the egg laying behavior in Aplysia4. Egg laying behavior is a result of several neuronal responses that include burst augmentation of cell R15, prolonged excitation of left lower quadrant neurons and inhibition of left upper quadrant neurons. BCPs have several functions in the bag cells2. a-BCP inhibits the left upper quardant cells, b-BCP excites L1, R1 and bag cells in the abdominal ganglion of Aplysia, g-BCP excites bag cells and d-BCP stimulates calcium release from the mitochondria5. This elecrophysiological chnages to the bag cells by the BCPs and other hormones culminates in egg-laying.

References
1.Rothman BS, Weir G, Dudek FE (1983a). Egg-laying hormone: direct action on the ovitestis Aplysia. Gen Comp Endocrinol, 52,134-141.
2.Rothman BS, Mayeri E, Brown RO, Yuan PM, Shively JE (1983b). Primary structure and neuronal effects of alpha-bag cell peptide, a second candidate neurotransmitter encoded by a single gene in bag cell neurons of Aplysia. Proc Natl Acad Sci, 80, 5753-5757.
3.Fisher JM, Sossin W, Newcomb R, Scheller RH (1988). Multiple neuropeptides derived from a common precursor are differentially packaged and transported. Cell, 54,813-822.
4.Hatcher NG, Sweedler JV (2008). Aplysia bag cells function as a distributed neurosecretory network. J. Neurophysiol.. 99, 333-343.
5.Gregg TN, Sherry DP, and James EB (1989). The Egg-Laying Hormone Family: Precursors, Products, and Functions. Bio Bull, 177, 210-217.
6.Owens DF, Menon JG, Rotham BS (1992). Structure-activity relationship of the neurotransmitter alpha-bag cell peptide on aplysia LUQ neurons: implications regarding its inactivation in the extra cellular space. J of Neurobiology, 6, 650-70.
7.Rothman BS, Dekruyfft S, Talebian SM, Menon JG, Squire CR, Yehll CH, and Lee TD (1992). Aplysia Peptide Neurotransmitters & Bag Cell Peptide, Phe-Met-Arg-Phe- amide, and Small Cardioexcitatory Peptide B Are Rapid Degraded by a Leucine Aminopeptidase-like Activity in Hemolymph, J Biol. Chem., 287, 35, 25135-140.
8.Karen JL, Ronald JK, John AC and Leonard KK (2004). Hyperosmotic media inhibit voltage-dependent calcium influx and peptide release in Aplysia neurons, J Memb. Biol., Vol 128, 41-52.

Basic Fibroblast Growth Factor (FGF) Inhibitory Peptides

Definition
Basic fibroblast growth factor (bFGF) is a potent heparin binding growth factor that promotes proliferation, migration and differentiation of mesenchymal and neuro ectodermal cells. It exerts its functions by binding to bFGF receptor on cell membranes1. bFGF inhibitory peptides are short peptides that inhibit bFGF receptor binding and its biological function1.

Discovery
bFGF inhibitory peptides were isolated from a phage epitope library using monoclonal antibodies raised against human recombinant bFGF. These monoclonal antibodies were found to efficiently block bFGF binding to its receptors1.

Classification
So far three bFGF inhibitory peptides have been characterized: bFGF inhibitory peptide, bFGF 119-126 and bFGF inhibitory peptide II1.

Structural Characteristics
The inhibitory peptides share a consensus sequence Pro-(Pro/Ser)-Gly-His-(Tyr/Phe)-Lys that corresponds to bFGF sequences at 13-18 and 120-1251.

Mode of action
bFGF 119-126 inhibits the dimerization and binding of bFGF receptors1. bFGF inhibitory peptide blocks the binding of bFGF-induced proliferation of vascular endothelial cells2,3. bFGF inhibitory peptide II has conformational similarity to the putative receptor binding domain of bFGF and hence blocks bFGF binding to its receptor4.

Functions
Inhibition or de-regulation of bFGF leads to pathological conditions involving angiogenesis and tumor growth2. bFGF inhibitory peptide II suppresses the proliferation of human glioma cells and is a potential new product for the treatment of malignant glioma4.

References
1.Avener Y, David A, Michal S, Janet L. G, Yehudit H, Shmuel C, David G, and Ephraim KK (1993). Isolation of peptides that inhibit binding of basic fibroblast growth factor to its receptor from a random phage-epitope library. Proc. Natl. Acad. Sci. USA, 90,10643-10647.
2.Luo J and Miller MW (1996). Ethanol inhibits bFGF-mediated proliferation of C6 glioma cells. J. Neurochem., 67, 1448-1456.
3.Torsten G, Hae YS, Gerald AM, and Ulrich P (2002). Shear Stress-induced Release of Basic Fibroblast Growth Factor from Endothelial Cells Is Mediated by Matrix Interaction via Integrin aVß3. J. Biol. Chem., 277, 23453 – 23458.
4.Gloe T, Sohn HY, Gerald AM, and Ulrich P (2002). Shear-stress induced release of bFGF from endothelial cells is mediated by matrix interaction via integrin alpha V beta 3. J. Biol. Chem., 277, 23453.